Loading clinical trials...
Loading clinical trials...
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Netherlands Cancer Institute
Collaborators
NCT06414434 · Liposarcoma, Recurrent Liposarcoma, and more
NCT05492682 · Melanoma (Skin), Triple-Negative Breast Cancer, and more
NCT06617572 · Synovial Sarcoma, Myxoid Liposarcoma
NCT03670069 · Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, and more
NCT03450122 · HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, and more
The Netherlands Cancer Institute
Amsterdam
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions